Fitness wearable company Whoop announced Tuesday that it is expanding access to its Advanced Labs testing to individuals who are non-members.
Whoop’s Advanced Labs testing combines blood testing—powered by Quest—with clinician-reviewed-results, artificial intelligence-driven insights and personalized recommendations. Insights from testing, which was first launched in 2025, include cardiovascular, metabolic and inflammatory health.
Eight in 10 users report discovering a “meaningful health finding,” with Advanced Labs and more than half receive results that may warrant follow-up with a provider, the company says.
"The goal is to help people move beyond simply collecting health data to actually understanding what it means, identifying areas they can focus on and having clearer conversations with their healthcare providers," Ami Bhatt, M.D., Whoop chief medical officer, told Fierce Healthcare.
Bhatt said Whoop's mission is to help individuals "live healthier, longer lives and unlock their potential."
"With Advanced Labs, we’re not just giving someone a set of lab results," Bhatt said. "The experience pairs comprehensive blood testing with clinician-reviewed context and a personalized report that helps the customer understand their results and identify potential next steps. That can give people a more informed starting point for conversations with their healthcare providers and for making changes in their daily lives."
Testing through Advanced Labs begins at approximately $150.
For Whoop members, Advanced Labs is available in the U.S. as an add-on subscription, a spokesperson told Fierce Healthcare. Plans vary based on test frequency, with one test per year at $199, two tests at $349, four tests at $599 or six tests at $899.
In addition to the expanded access to the capability, Whoop is adding Grail’s multi-cancer early detection test to the lineup, including for non-members. The test is available at nearly 2,000 Quest locations across the U.S. Results are delivered to the Whoop app.
“We’re excited to work with WHOOP to bring Galleri to a community already highly engaged in understanding, monitoring and improving their health,” said Megan Hall, Ph.D, Grail vice president of medical affairs, in a statement. “By making multi-cancer early detection available through trusted platforms that are part of people’s everyday health journeys, we can help more people take a proactive step toward finding cancer earlier, when treatment may be more effective.”
Whoop now counts more than 3 million members globally and raised a massive $575 million raise at the end of March, Fierce Biotech reported. The funding boosted Whoop's valuation to $10.1 billion.
Tuesday’s launch comes as Whoop continues its expansion from a fitness tracker to a clinical health platform.
In mid-June, it announced a partnership with HealthEx to allow users to connect medical records directly within its app. Users can choose whether to connect records, see what data is shared, and disconnect the features at any time.
In May, the company also introduced on-demand video consultations with licensed clinicians through its app.